I-Mab ADR (NQ: IMAB )

55.09 +5.46 (+11.00%)

Official Closing Price Updated: 4:29 PM EDT, Apr 14, 2021 Add to My Watchlist

Price and Volume

Volume	642,300
Open	49.64
Bid (Size)	52.30 (1)
Ask (Size)	55.50 (1)
Prev. Close	49.63
Today's Range	49.64 - 56.66
52wk Range	12.95 - 65.94
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

I-Mab Announces Selected Poster Presentation of CD73 Antibody Uliledlimab at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

April 14, 2021

Shanghai Genchem Co., Ltd. (Genechem) Announces Global Collaboration on Bispecific Antibodies

April 06, 2021

Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel therapeutics, today announced the execution of a global collaboration with...

Performance

YTD	+21.77%	+21.77%
1 Month	+10.11%	+10.11%
3 Month	+9.26%	+9.26%
6 Month	+38.59%	+38.59%
1 Year	+323.77%	+323.77%

More News

I-Mab and ABL Bio Announce First Patient Dosed in Phase 1 Trial of Bispecific Antibody TJ-L14B/ABL503 in Patients with Advanced or Metastatic Solid Tumors

April 06, 2021

I-Mab Announces Upcoming Participation at April Conferences

March 31, 2021

I-Mab and ABL Bio Receive US FDA Approval to Initiate Phase 1 Trial of Bispecific Antibody TJ-CD4B/ABL111 in Patients with Advanced or Metastatic Solid Tumors

March 30, 2021

I-Mab Reports Financial Results for Full Year of 2020 and Provides Business Updates

March 29, 2021

I-Mab to Host 2021 R&D Day

March 24, 2021

I-Mab Files Prospectus Supplement for Shelf Registration for Hillhouse

March 19, 2021

I-Mab To Present Differentiated Mechanism of Action and Preclinical Data for Anti-CD73 Antibody Uliledlimab at 2021 American Association for Cancer Research Annual Meeting

March 11, 2021

Week in Review: Sorrento Acquires ACEA in $488 Million Deal between Two San Diego-China Oncology Biopharmas

April 10, 2021

Week In Review: Sorrento Acquires ACEA In $488 Million Deal Between Two San Diego-China Oncology Biopharmas

April 10, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.